14-day Premium Trial Subscription Try For FreeTry Free

Meridian Bioscience: Q3 Earnings Insights

08:27am, Friday, 06'th Aug 2021
Shares of Meridian Bioscience (NASDAQ:VIVO) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share decreased 60.00% year over year to $0.22, which missed the e
CINCINNATI, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter ended June 30, 2021.
CINCINNATI, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it closed the pr
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CINCINNATI, July 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a defi
CINCINNATI, July 14, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter fiscal 2021
In the latest trading session, Meridian Bioscience (VIVO) closed at $22.05, marking a +1.61% move from the previous day.
If The COVID-19 Delta Variant Spreads This Fall, Meridian Is Still A Buy
Meridian Bioscience (VIVO) closed the most recent trading day at $22.46, moving +1.26% from the previous trading session.
CINCINNATI, June 28, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has re-submit
Meridian Bioscience (VIVO) closed the most recent trading day at $20.90, moving +0.87% from the previous trading session.
In the latest trading session, Meridian Bioscience (VIVO) closed at $20.88, marking a +1.11% move from the previous day.
CINCINNATI, May 27, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today participation in two upcoming investor conferences. Jack Kenny, Chief Executive Officer, will part

IYH: Healthcare Dashboard For May

03:31pm, Monday, 17'th May 2021
IYH: Healthcare Dashboard For May
CINCINNATI, May 17, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE